Treace Medical Concepts Inc Cash Flow Conversion Efficiency
Treace Medical Concepts Inc cash flow conversion efficiency. Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has a cash flow conversion efficiency ratio of 0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.23 Million) by net assets ($77.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Treace Medical Concepts Inc (2019–2025)
Cash flow conversion efficiency of Treace Medical Concepts Inc from 2019 to 2025. This chart illustrates how Treace Medical Concepts Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View TMCI live share price for real-time trading data and today's change.
Treace Medical Concepts Inc Cash Flow Conversion Ratio Explained
Treace Medical Concepts Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Treace Medical Concepts Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Treace Medical Concepts Inc ranked by their cash flow conversion efficiency. Also see TMCI stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NexG Bhd
KLSE:5216
|
0.072x |
|
Síminn hf
IC:SIMINN
|
0.082x |
|
Martifer SGPS S.A
LS:MAR
|
0.125x |
|
Comefly Outdoor Co Ltd
SHG:603908
|
0.074x |
|
Dongsung FineTec Co. Ltd
KQ:033500
|
-0.011x |
|
Asia Cuanon Tech (Shanghai)
SHG:603378
|
-0.615x |
|
centrotherm international AG
F:CTNK
|
0.077x |
|
Tanvex BioPharma Inc
TW:6541
|
-0.058x |
Annual Cash Flow Conversion Efficiency for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Treace Medical Concepts Inc from 2019 to 2025. Review Treace Medical Concepts Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $87.33 Million | $-15.97 Million | -0.183x | +44.46% |
| 2024-12-31 | $112.89 Million | $-37.17 Million | -0.329x | -31.35% |
| 2023-12-31 | $137.94 Million | $-34.58 Million | -0.251x | +50.50% |
| 2022-12-31 | $60.53 Million | $-30.65 Million | -0.506x | -174.10% |
| 2021-12-31 | $93.07 Million | $-17.19 Million | -0.185x | +96.81% |
| 2020-12-31 | $776.00K | $-4.49 Million | -5.791x | -138.58% |
| 2019-12-31 | $3.16 Million | $-7.67 Million | -2.427x | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more